Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	molecular adaptor activity	NOLC1 BCL9L DLGAP2 DLGAP1 SYNPO2 PPP2R3A SUPT20H MAPT TICAM1 BRD4 DLGAP4 NACA BCORL1 LAMP2 POLD3 EPN1 THRAP3	5.83e-06	1356	73	17	GO:0060090
GeneOntologyMolecularFunction	actin binding	EPS8 SYNPO2 MAPT MYPN PHACTR3 SYNPO2L LMOD1 MYO15A MYO16	6.07e-05	479	73	9	GO:0003779
GeneOntologyMolecularFunction	protein-macromolecule adaptor activity	NOLC1 BCL9L SYNPO2 PPP2R3A SUPT20H MAPT TICAM1 BRD4 NACA BCORL1 LAMP2 POLD3 EPN1 THRAP3	6.79e-05	1160	73	14	GO:0030674
GeneOntologyCellularComponent	mucus layer	MUC2 MUC5AC	3.70e-05	3	74	2	GO:0070701
GeneOntologyCellularComponent	postsynaptic specialization	PRR12 EPS8 DLGAP2 DLGAP1 MAPT DLGAP4 PRKCG PRRT2 BSN	6.94e-05	503	74	9	GO:0099572
GeneOntologyCellularComponent	postsynaptic density	PRR12 EPS8 DLGAP2 DLGAP1 MAPT PRKCG PRRT2 BSN	1.91e-04	451	74	8	GO:0014069
GeneOntologyCellularComponent	asymmetric synapse	PRR12 EPS8 DLGAP2 DLGAP1 MAPT PRKCG PRRT2 BSN	2.79e-04	477	74	8	GO:0032279
GeneOntologyCellularComponent	neuron to neuron synapse	PRR12 EPS8 DLGAP2 DLGAP1 MAPT PRKCG PRRT2 BSN	5.15e-04	523	74	8	GO:0098984
GeneOntologyCellularComponent	dendrite	DLGAP2 MAPT DLGAP4 LRP2 LAMP1 MCRS1 PRKCG PRRT2 BSN AGAP2	8.56e-04	858	74	10	GO:0030425
GeneOntologyCellularComponent	postsynapse	PRR12 EPS8 DLGAP2 DLGAP1 MAPT DLGAP4 PRKCG PRRT2 BSN EPN1 AGAP2	8.67e-04	1018	74	11	GO:0098794
GeneOntologyCellularComponent	dendritic tree	DLGAP2 MAPT DLGAP4 LRP2 LAMP1 MCRS1 PRKCG PRRT2 BSN AGAP2	8.72e-04	860	74	10	GO:0097447
GeneOntologyCellularComponent	actin cytoskeleton	DOCK5 SYNPO2 SH3PXD2A SYNPO2L LMOD1 MYO15A CTTNBP2NL MYO16	9.66e-04	576	74	8	GO:0015629
GeneOntologyCellularComponent	chromatin silencing complex	SIRT2 RRP8	1.09e-03	14	74	2	GO:0005677
GeneOntologyCellularComponent	ficolin-1-rich granule membrane	NBEAL2 LAMP1 LAMP2	1.32e-03	61	74	3	GO:0101003
GeneOntologyCellularComponent	autolysosome	LAMP1 LAMP2	1.82e-03	18	74	2	GO:0044754
Domain	TIL_dom	ZAN LRP2 MUC2 MUC5AC	1.97e-07	14	72	4	IPR002919
Domain	SAPAP	DLGAP2 DLGAP1 DLGAP4	5.46e-07	5	72	3	IPR005026
Domain	GKAP	DLGAP2 DLGAP1 DLGAP4	5.46e-07	5	72	3	PF03359
Domain	TIL	ZAN MUC2 MUC5AC	1.18e-05	12	72	3	PF01826
Domain	C8	ZAN MUC2 MUC5AC	1.18e-05	12	72	3	PF08742
Domain	Unchr_dom_Cys-rich	ZAN MUC2 MUC5AC	1.53e-05	13	72	3	IPR014853
Domain	C8	ZAN MUC2 MUC5AC	1.53e-05	13	72	3	SM00832
Domain	VWD	ZAN MUC2 MUC5AC	2.97e-05	16	72	3	SM00216
Domain	VWF_type-D	ZAN MUC2 MUC5AC	2.97e-05	16	72	3	IPR001846
Domain	VWFD	ZAN MUC2 MUC5AC	2.97e-05	16	72	3	PS51233
Domain	VWD	ZAN MUC2 MUC5AC	2.97e-05	16	72	3	PF00094
Domain	LAMP_1	LAMP1 LAMP2	4.39e-05	3	72	2	PS00310
Domain	LAMP_2	LAMP1 LAMP2	4.39e-05	3	72	2	PS00311
Domain	LAMP_CS	LAMP1 LAMP2	4.39e-05	3	72	2	IPR018134
Domain	VWC_out	ZAN MUC2 MUC5AC	5.09e-05	19	72	3	SM00215
Domain	LAMP_3	LAMP1 LAMP2	8.75e-05	4	72	2	PS51407
Domain	DUF3504	ZMYM4 ZMYM3	1.45e-04	5	72	2	IPR021893
Domain	Lamp	LAMP1 LAMP2	1.45e-04	5	72	2	PF01299
Domain	DUF3504	ZMYM4 ZMYM3	1.45e-04	5	72	2	PF12012
Domain	Lysosome-assoc_membr_glycop	LAMP1 LAMP2	1.45e-04	5	72	2	IPR002000
Domain	WxxW_domain	MUC2 MUC5AC	2.18e-04	6	72	2	IPR025155
Domain	Mucin2_WxxW	MUC2 MUC5AC	2.18e-04	6	72	2	PF13330
Domain	Znf_MYM	ZMYM4 ZMYM3	3.04e-04	7	72	2	IPR010507
Domain	zf-FCS	ZMYM4 ZMYM3	3.04e-04	7	72	2	PF06467
Domain	VWFC_1	ZAN MUC2 MUC5AC	3.58e-04	36	72	3	PS01208
Domain	TRASH_dom	ZMYM4 ZMYM3	4.04e-04	8	72	2	IPR011017
Domain	TRASH	ZMYM4 ZMYM3	4.04e-04	8	72	2	SM00746
Domain	VWC	ZAN MUC2 MUC5AC	4.21e-04	38	72	3	SM00214
Domain	VWFC_2	ZAN MUC2 MUC5AC	4.21e-04	38	72	3	PS50184
Domain	VWF_dom	ZAN MUC2 MUC5AC	5.66e-04	42	72	3	IPR001007
Domain	SH3	DOCK5 EPS8 CASKIN2 SH3PXD2A MYO15A	1.47e-03	216	72	5	SM00326
Domain	SH3	DOCK5 EPS8 CASKIN2 SH3PXD2A MYO15A	1.47e-03	216	72	5	PS50002
Domain	SH3_domain	DOCK5 EPS8 CASKIN2 SH3PXD2A MYO15A	1.60e-03	220	72	5	IPR001452
Domain	CTCK_1	MUC2 MUC5AC	2.15e-03	18	72	2	PS01185
Domain	ANK_REPEAT	CASKIN2 BCORL1 MUC16 MYO16 AGAP2	2.93e-03	253	72	5	PS50088
Domain	ANK_REP_REGION	CASKIN2 BCORL1 MUC16 MYO16 AGAP2	2.98e-03	254	72	5	PS50297
Domain	CT	MUC2 MUC5AC	3.22e-03	22	72	2	SM00041
Domain	Cys_knot_C	MUC2 MUC5AC	4.15e-03	25	72	2	IPR006207
Domain	CTCK_2	MUC2 MUC5AC	4.15e-03	25	72	2	PS01225
Domain	Myosin_head_motor_dom	MYO15A MYO16	9.42e-03	38	72	2	IPR001609
Domain	MYOSIN_MOTOR	MYO15A MYO16	9.42e-03	38	72	2	PS51456
Pathway	REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS	MUC16 MUC2 MUC5AC	7.11e-05	21	55	3	MM15706
Pathway	REACTOME_SENSORY_PROCESSING_OF_SOUND	EPS8 TMIE BSN MYO15A	2.27e-04	77	55	4	M41822
Pathway	REACTOME_NEUREXINS_AND_NEUROLIGINS	DLGAP2 DLGAP1 DLGAP4	2.57e-04	32	55	3	MM15326
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	NOLC1 EPS15L1 SRSF6 MAPT UBAP2L BRD4 AFF1 CHAMP1 PRG4 CTTNBP2NL THRAP3 ZMYM4 ZMYM3 WDR44	1.04e-09	774	75	14	15302935
Pubmed	H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.	DOCK5 NOLC1 PRR12 MAP7D1 SUPT20H SRSF6 BRD4 BCORL1 MECOM MCRS1 RRP8 UBN2 CHAMP1 THRAP3 CASZ1 ZMYM4 ZMYM3	1.74e-09	1294	75	17	30804502
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	PRR12 BCL9L EPS8 MAP7D1 SUPT20H SPRR2A NACA OS9 MCRS1 LAMP2 RRP8 UBN2 EPN1 CTTNBP2NL CASZ1 ZMYM4 ZMYM3 C6orf132	2.15e-09	1497	75	18	31527615
Pubmed	Qualitative and quantitative analyses of protein phosphorylation in naive and stimulated mouse synaptosomal preparations.	DLGAP1 EPS15L1 MAPT UBAP2L SH3PXD2A DLGAP4 KCNQ2 PRKCG BSN AGAP2	4.01e-09	347	75	10	17114649
Pubmed	A probability-based approach for high-throughput protein phosphorylation analysis and site localization.	NOLC1 EPS15L1 UBAP2L MYPN NAV2 MCRS1 RRP8 CHAMP1 CTTNBP2NL THRAP3 WDR44	1.11e-08	503	75	11	16964243
Pubmed	Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.	NOLC1 BCL9L DLGAP2 DLGAP1 EPS15L1 MAPT UBAP2L DLGAP4 NACA KCNQ2 PRKCG POLD3 BSN THRAP3 AGAP2	1.77e-08	1139	75	15	36417873
Pubmed	Differential mRNA expression and protein localization of the SAP90/PSD-95-associated proteins (SAPAPs) in the nervous system of the mouse.	DLGAP2 DLGAP1 DLGAP4	9.60e-08	5	75	3	15024750
Pubmed	Expression of Muc19/Smgc gene products during murine sublingual gland development: cytodifferentiation and maturation of salivary mucous cells.	MUC16 MUC2 MUC5AC	1.92e-07	6	75	3	19110483
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	PRR12 MAP7D1 BRD4 BCORL1 LRP2 MECOM CHAMP1 ZMYM4 ZMYM3	2.99e-07	418	75	9	34709266
Pubmed	Human transcription factor protein interaction networks.	NOLC1 PRR12 BCL9L MAP7D1 SUPT20H UBAP2L NACA BCORL1 LRP2 ETV5 MECOM MCRS1 UBN2 ZMYM4 ZMYM3	3.34e-07	1429	75	15	35140242
Pubmed	SAPAPs. A family of PSD-95/SAP90-associated proteins localized at postsynaptic density.	DLGAP2 DLGAP1 DLGAP4	3.35e-07	7	75	3	9115257
Pubmed	Proline-rich synapse-associated proteins ProSAP1 and ProSAP2 interact with synaptic proteins of the SAPAP/GKAP family.	DLGAP2 DLGAP1 DLGAP4	3.35e-07	7	75	3	10527873
Pubmed	Proteomic Analysis of the EWS-Fli-1 Interactome Reveals the Role of the Lysosome in EWS-Fli-1 Turnover.	PRR12 BCL9L SRSF6 MAPT NACA BCORL1 LAMP1 LAMP2 UBN2	3.44e-07	425	75	9	24999758
Pubmed	Ca2+ entry through mechanotransduction channels localizes BAIAP2L2 to stereocilia tips.	EPS8 TMIE MYO15A	5.35e-07	8	75	3	35044843
Pubmed	Dopaminergic control of autophagic-lysosomal function implicates Lmx1b in Parkinson's disease.	NR4A2 LAMP1 LAMP2 BSN	8.81e-07	34	75	4	25915474
Pubmed	Systematic analysis of human protein complexes identifies chromosome segregation proteins.	NOLC1 EPS15L1 MAP7D1 SRSF6 MYPN NACA MCRS1 CHAMP1 CTTNBP2NL THRAP3 ZMYM4 ZMYM3 FAM110B	1.05e-06	1155	75	13	20360068
Pubmed	Proximity-dependent Mapping of the Androgen Receptor Identifies Kruppel-like Factor 4 as a Functional Partner.	PRR12 BCL9L BRD4 MCRS1 UBN2 CHAMP1 CASZ1	1.89e-06	268	75	7	33640491
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	EPS8 DLGAP2 DLGAP1 EPS15L1 MAP7D1 SIRT2 MAPT UBAP2L DLGAP4 KCNQ2 PRKCG BSN THRAP3 AGAP2	2.00e-06	1431	75	14	37142655
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	NOLC1 CASKIN2 NBEAL2 NACA NAV2 BSN CHAMP1 CTTNBP2NL ZMYM4	2.10e-06	529	75	9	14621295
Pubmed	NuRD subunit CHD4 regulates super-enhancer accessibility in rhabdomyosarcoma and represents a general tumor dependency.	NOLC1 BRD4 CHAMP1 ZMYM4 ZMYM3	3.02e-06	103	75	5	32744500
Pubmed	Proteome-scale mapping of binding sites in the unstructured regions of the human proteome.	DOCK5 DLGAP2 SYNPO2 AFF1 BSN EPN1 C6orf132 FAM110B	4.19e-06	430	75	8	35044719
Pubmed	Impaired OTUD7A-dependent Ankyrin regulation mediates neuronal dysfunction in mouse and human models of the 15q13.3 microdeletion syndrome.	EPS8 DLGAP2 DLGAP1 DLGAP4 NACA KCNQ2	4.45e-06	197	75	6	36604605
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	NOLC1 MAP7D1 SUPT20H MAPT BRD4 RTL9 LRP2 MECOM MCRS1 SCEL CHAMP1 ZMYM3	4.56e-06	1116	75	12	31753913
Pubmed	Intestinal MUC2 and gastric M1/MUC5AC in preneoplastic lesions induced by 1,2-dimethylhydrazine in rat: a sequential analysis.	MUC2 MUC5AC	4.59e-06	2	75	2	17203232
Pubmed	Arrested maturation of Neisseria-containing phagosomes in the absence of the lysosome-associated membrane proteins, LAMP-1 and LAMP-2.	LAMP1 LAMP2	4.59e-06	2	75	2	17506821
Pubmed	Differential expression of the lysosome-associated membrane proteins in normal human tissues.	LAMP1 LAMP2	4.59e-06	2	75	2	10222041
Pubmed	Lysosomal membrane-associated glycoproteins are differentially expressed in acute and chronic human thymic involution.	LAMP1 LAMP2	4.59e-06	2	75	2	17048695
Pubmed	The cDNA sequence of mouse LAMP-2. Evidence for two classes of lysosomal membrane glycoproteins.	LAMP1 LAMP2	4.59e-06	2	75	2	2318880
Pubmed	Alterations of the ocular surface epithelial MUC16 and goblet cell MUC5AC in patients with atopic keratoconjunctivitis.	MUC16 MUC5AC	4.59e-06	2	75	2	18782111
Pubmed	The apoptosis/autophagy paradox: autophagic vacuolization before apoptotic death.	LAMP1 LAMP2	4.59e-06	2	75	2	15985464
Pubmed	Lysosome-associated protein 1 (LAMP-1) and lysosome-associated protein 2 (LAMP-2) in a larger family carrier of Fabry disease.	LAMP1 LAMP2	4.59e-06	2	75	2	24334114
Pubmed	Enhanced discrimination of malignant from benign pancreatic disease by measuring the CA 19-9 antigen on specific protein carriers.	MUC16 MUC5AC	4.59e-06	2	75	2	22220206
Pubmed	Differential expression of ABH histo-blood group antigens and LAMPs in infantile hemangioma.	LAMP1 LAMP2	4.59e-06	2	75	2	16570122
Pubmed	Disturbed cholesterol traffic but normal proteolytic function in LAMP-1/LAMP-2 double-deficient fibroblasts.	LAMP1 LAMP2	4.59e-06	2	75	2	15121881
Pubmed	Cloning of cDNAs encoding human lysosomal membrane glycoproteins, h-lamp-1 and h-lamp-2. Comparison of their deduced amino acid sequences.	LAMP1 LAMP2	4.59e-06	2	75	2	3198605
Pubmed	Methylation status of promoters and expression of MUC2 and MUC5AC mucins in pancreatic cancer cells.	MUC2 MUC5AC	4.59e-06	2	75	2	12527922
Pubmed	Characterization and cloning of lgp110, a lysosomal membrane glycoprotein from mouse and rat cells.	LAMP1 LAMP2	4.59e-06	2	75	2	2142158
Pubmed	Lysosome-associated membrane proteins-1 and -2 (LAMP-1 and LAMP-2) assemble via distinct modes.	LAMP1 LAMP2	4.59e-06	2	75	2	27663661
Pubmed	Differential expression of LAMPs and ubiquitin in human thymus.	LAMP1 LAMP2	4.59e-06	2	75	2	19343823
Pubmed	A novel dephosphorylation targeting chimera selectively promoting tau removal in tauopathies.	PPP2R3A MAPT	4.59e-06	2	75	2	34262014
Pubmed	The polylactosaminoglycans of human lysosomal membrane glycoproteins lamp-1 and lamp-2. Localization on the peptide backbones.	LAMP1 LAMP2	4.59e-06	2	75	2	2243102
Pubmed	Purification and characterization of human lysosomal membrane glycoproteins.	LAMP1 LAMP2	4.59e-06	2	75	2	2912382
Pubmed	Lysosome-associated membrane proteins (LAMPs) regulate intracellular positioning of mitochondria in MC3T3-E1 cells.	LAMP1 LAMP2	4.59e-06	2	75	2	25246127
Pubmed	Confirmation of the chromosomal localization of human lamp genes and their exclusion as candidate genes for Salla disease.	LAMP1 LAMP2	4.59e-06	2	75	2	1959930
Pubmed	LAMP-2 absence interferes with plasma membrane repair and decreases T. cruzi host cell invasion.	LAMP1 LAMP2	4.59e-06	2	75	2	28586379
Pubmed	Mucolytic activity of bacterial and human chitinases.	MUC2 MUC5AC	4.59e-06	2	75	2	17321686
Pubmed	Altered expression of MUC2 and MUC5AC in progression of colorectal carcinoma.	MUC2 MUC5AC	4.59e-06	2	75	2	20731025
Pubmed	Assignment of O-glycan attachment sites to the hinge-like regions of human lysosomal membrane glycoproteins lamp-1 and lamp-2.	LAMP1 LAMP2	4.59e-06	2	75	2	8323299
Pubmed	CD107a (LAMP-1) and CD107b (LAMP-2).	LAMP1 LAMP2	4.59e-06	2	75	2	12144129
Pubmed	The genes of major lysosomal membrane glycoproteins, lamp-1 and lamp-2. 5'-flanking sequence of lamp-2 gene and comparison of exon organization in two genes.	LAMP1 LAMP2	4.59e-06	2	75	2	8517882
Pubmed	In vivo glycosylation of mucin tandem repeats.	MUC2 MUC5AC	4.59e-06	2	75	2	11445551
Pubmed	Two human lysosomal membrane glycoproteins, h-lamp-1 and h-lamp-2, are encoded by genes localized to chromosome 13q34 and chromosome Xq24-25, respectively.	LAMP1 LAMP2	4.59e-06	2	75	2	2332441
Pubmed	Effects of lysosomal membrane protein depletion on the Salmonella-containing vacuole.	LAMP1 LAMP2	4.59e-06	2	75	2	18958159
Pubmed	LAMP proteins are required for fusion of lysosomes with phagosomes.	LAMP1 LAMP2	4.59e-06	2	75	2	17245426
Pubmed	The Major Lysosomal Membrane Proteins LAMP-1 and LAMP-2 Participate in Differentiation of C2C12 Myoblasts.	LAMP1 LAMP2	4.59e-06	2	75	2	30068868
Pubmed	Studies of mucus in mouse stomach, small intestine, and colon. II. Gastrointestinal mucus proteome reveals Muc2 and Muc5ac accompanied by a set of core proteins.	MUC2 MUC5AC	4.59e-06	2	75	2	23832517
Pubmed	Studies of mucus in mouse stomach, small intestine, and colon. III. Gastrointestinal Muc5ac and Muc2 mucin O-glycan patterns reveal a regiospecific distribution.	MUC2 MUC5AC	4.59e-06	2	75	2	23832516
Pubmed	Sensitization to the lysosomal cell death pathway by oncogene-induced down-regulation of lysosome-associated membrane proteins 1 and 2.	LAMP1 LAMP2	4.59e-06	2	75	2	18701486
Pubmed	Temporal analysis of goblet cells and mucin gene expression in murine models of allergic asthma.	MUC2 MUC5AC	4.59e-06	2	75	2	14594655
Pubmed	Lysosomal membrane glycoproteins bind cholesterol and contribute to lysosomal cholesterol export.	LAMP1 LAMP2	4.59e-06	2	75	2	27664420
Pubmed	Role of host lysosomal associated membrane protein (LAMP) in Trypanosoma cruzi invasion and intracellular development.	LAMP1 LAMP2	4.59e-06	2	75	2	20561595
Pubmed	Pathobiological implications of mucin (MUC) expression in the outcome of small bowel cancer.	MUC16 MUC5AC	4.59e-06	2	75	2	24722639
Pubmed	Abnormal subcellular distribution of mature MUC2 and de novo MUC5AC mucins in adenomas of the rectum: immunohistochemical detection using non-VNTR antibodies to MUC2 and MUC5AC peptide.	MUC2 MUC5AC	4.59e-06	2	75	2	12820724
Pubmed	Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.	EPS8 SIRT2 SUPT20H BCORL1 MECOM BSN UBN2 ZMYM4 ZMYM3	4.95e-06	588	75	9	38580884
Pubmed	Prediction of the coding sequences of unidentified human genes. VIII. 78 new cDNA clones from brain which code for large proteins in vitro.	SH3PXD2A RRP8 BSN ZMYM4	4.99e-06	52	75	4	9455477
Pubmed	The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.	NOLC1 EPS15L1 SRSF6 UBAP2L BRD4 BCORL1 RRP8 UBN2 CHAMP1 THRAP3 ZMYM4	6.17e-06	954	75	11	36373674
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	DLGAP2 DLGAP1 EPS15L1 MAP7D1 UBAP2L DLGAP4 PRKCG BSN UBN2 THRAP3 AGAP2	6.74e-06	963	75	11	28671696
Pubmed	Systematic identification of SH3 domain-mediated human protein-protein interactions by peptide array target screening.	DLGAP2 DLGAP1 BRD4 DLGAP4 LRP2 PRG4 CSDC2	7.28e-06	329	75	7	17474147
Pubmed	Mucin gene expression in human laryngeal epithelia: effect of laryngopharyngeal reflux.	MUC16 MUC2 MUC5AC	7.68e-06	18	75	3	18834073
Pubmed	Comprehensive identification of phosphorylation sites in postsynaptic density preparations.	EPS15L1 MAPT DLGAP4 BSN THRAP3 AGAP2	1.11e-05	231	75	6	16452087
Pubmed	Interaction network of human early embryonic transcription factors.	PRR12 BCL9L BCORL1 MECOM UBN2 ZMYM4 ZMYM3	1.11e-05	351	75	7	38297188
Pubmed	MESD is essential for apical localization of megalin/LRP2 in the visceral endoderm.	LRP2 LAMP1 LAMP2	1.25e-05	21	75	3	21337463
Pubmed	A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning.	NOLC1 EPS15L1 SIRT2 SRSF6 UBAP2L TICAM1 MYPN MCRS1 POLD3 EPN1 THRAP3	1.36e-05	1038	75	11	26673895
Pubmed	Assessment of mucin-related gene alterations following treatment with rebamipide ophthalmic suspension in Sjögren's syndrome-associated dry eyes.	MUC16 MUC5AC	1.37e-05	3	75	2	33232357
Pubmed	Stimulation of CD107 affects LPS-induced cytokine secretion and cellular adhesion through the ERK signaling pathway in the human macrophage-like cell line, THP-1.	LAMP1 LAMP2	1.37e-05	3	75	2	23603048
Pubmed	Distribution of lysosome-associated membrane proteins-1 and -2, and cathepsin D in eosinophilic granular bodies: possible relationship to cyst development in pilocytic astrocytomas.	LAMP1 LAMP2	1.37e-05	3	75	2	20926008
Pubmed	Differences in the expression of mucins in various forms of cystitis glandularis.	MUC2 MUC5AC	1.37e-05	3	75	2	17659847
Pubmed	The lysosomal polypeptide transporter TAPL: more than a housekeeping factor?	LAMP1 LAMP2	1.37e-05	3	75	2	21194361
Pubmed	Endolyn is a mucin-like type I membrane protein targeted to lysosomes by its cytoplasmic tail.	LAMP1 LAMP2	1.37e-05	3	75	2	10620506
Pubmed	Fucosylation of LAMP-1 and LAMP-2 by FUT1 correlates with lysosomal positioning and autophagic flux of breast cancer cells.	LAMP1 LAMP2	1.37e-05	3	75	2	27560716
Pubmed	Cadherin-catenin adhesion system and mucin expression: a comparison between young and older patients with gastric carcinoma.	MUC2 MUC5AC	1.37e-05	3	75	2	18825309
Pubmed	Cloning and mapping of members of the MYM family.	ZMYM4 ZMYM3	1.37e-05	3	75	2	10486218
Pubmed	Adenomatous and foveolar gastric dysplasia: distinct patterns of mucin expression and background intestinal metaplasia.	MUC2 MUC5AC	1.37e-05	3	75	2	18300795
Pubmed	Gene expression profiling of colorectal mucinous adenocarcinomas.	MUC2 MUC5AC	1.37e-05	3	75	2	20485009
Pubmed	Phase separation-mediated condensation of Whirlin-Myo15-Eps8 stereocilia tip complex.	EPS8 MYO15A	1.37e-05	3	75	2	33626355
Pubmed	Expression of aberrant mucins in lobular carcinoma with histiocytoid feature of the breast.	MUC2 MUC5AC	1.37e-05	3	75	2	17333267
Pubmed	Clinicopathological and prognostic significance of MUC-2, MUC-4 and MUC-5AC expression in japanese gastric carcinomas.	MUC2 MUC5AC	1.37e-05	3	75	2	23464473
Pubmed	The lysosomal polypeptide transporter TAPL is stabilized by interaction with LAMP-1 and LAMP-2.	LAMP1 LAMP2	1.37e-05	3	75	2	22641697
Pubmed	Dual-specificity tyrosine phosphorylation-regulated kinase 1A (Dyrk1A) modulates serine/arginine-rich protein 55 (SRp55)-promoted Tau exon 10 inclusion.	SRSF6 MAPT	1.37e-05	3	75	2	22767602
Pubmed	Meconium ileus in cystic fibrosis is not linked to central repetitive region length variation in MUC1, MUC2, and MUC5AC.	MUC2 MUC5AC	1.37e-05	3	75	2	24920497
Pubmed	Mucin gene polymorphisms in otitis media patients.	MUC2 MUC5AC	1.37e-05	3	75	2	19718741
Pubmed	Lysosomal LAMP proteins regulate lysosomal pH by direct inhibition of the TMEM175 channel.	LAMP1 LAMP2	1.37e-05	3	75	2	37390818
Pubmed	Phosphoproteomic analysis of the developing mouse brain.	DLGAP1 MAPT DLGAP4 NACA MCRS1 CTTNBP2NL	1.58e-05	246	75	6	15345747
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	NOLC1 MAP7D1 CASKIN2 MAPT SH3PXD2A BRD4 NAV2 PRKCG C6orf132 FAM110B	1.59e-05	861	75	10	36931259
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	EPS15L1 UBAP2L BRD4 UBN2 CHAMP1 THRAP3 ZMYM4 WDR44	2.44e-05	549	75	8	38280479
Pubmed	Identification and functional characterization of transcriptional activators in human cells.	PRR12 SUPT20H BRD4 BCORL1 MECOM MYO15A CASZ1	2.48e-05	398	75	7	35016035
Pubmed	Proteomic Analysis of the Spinophilin Interactome in Rodent Striatum Following Psychostimulant Sensitization.	DLGAP2 DLGAP1 SIRT2 DLGAP4 PRKCG BSN AGAP2	2.68e-05	403	75	7	30562941
Pubmed	Loss of Cubilin, the intrinsic factor-vitamin B12 receptor, impairs visceral endoderm endocytosis and endodermal patterning in the mouse.	LRP2 LAMP1 LAMP2	2.71e-05	27	75	3	31308417
Pubmed	Lysosomal accumulation of SCMAS (subunit c of mitochondrial ATP synthase) in neurons of the mouse model of mucopolysaccharidosis III B.	LAMP1 LAMP2	2.75e-05	4	75	2	17185018
Pubmed	Control of stereocilia length during development of hair bundles.	TMIE MYO15A	2.75e-05	4	75	2	37011103
Interaction	SHANK3 interactions	BCL9L DLGAP2 DLGAP1 SIRT2 ZAN MAPT DLGAP4 NACA KCNQ2 MCRS1 PRKCG PRRT2 MYO15A THRAP3 AGAP2	2.87e-10	496	74	15	int:SHANK3
Interaction	DLG1 interactions	DLGAP2 DLGAP1 MAPT DLGAP4 LRP2 LAMP1 LAMP2 PRRT2 AGAP2	2.34e-07	240	74	9	int:DLG1
Interaction	GRIN1 interactions	DOCK5 EPS8 DLGAP1 DLGAP4 PRKCG BSN AGAP2	1.56e-06	154	74	7	int:GRIN1
Interaction	PPP1R9B interactions	EPS8 DLGAP2 DLGAP1 SIRT2 DLGAP4 NACA NAV2 KCNQ2 MECOM PRKCG BSN AGAP2	2.74e-06	626	74	12	int:PPP1R9B
Interaction	EGR2 interactions	PRR12 BCL9L BCORL1 MECOM MCRS1 UBN2 ZMYM4	3.12e-06	171	74	7	int:EGR2
Interaction	KLF8 interactions	NOLC1 PRR12 MAP7D1 SUPT20H BCORL1 MECOM UBN2 ZMYM4 ZMYM3	3.21e-06	329	74	9	int:KLF8
Interaction	PLPP3 interactions	MAPT LAMP1 LAMP2 PRRT2	9.02e-06	36	74	4	int:PLPP3
Interaction	TNIK interactions	DLGAP1 MAPT KCNQ2 LAMP1 PRKCG UBN2 CTTNBP2NL THRAP3 AGAP2	1.05e-05	381	74	9	int:TNIK
Interaction	GAS7 interactions	MAPT BRD4 MECOM MCRS1	1.12e-05	38	74	4	int:GAS7
Interaction	DLGAP2 interactions	DLGAP2 DLGAP1 DLGAP4 AGAP2	1.25e-05	39	74	4	int:DLGAP2
Interaction	DIS3L2 interactions	SRSF6 MAPT TICAM1 ZMYM3	1.25e-05	39	74	4	int:DIS3L2
Interaction	H3C1 interactions	MAP7D1 SIRT2 SUPT20H MAPT BRD4 NACA NAV2 MECOM POLD3 UBN2 CHAMP1 THRAP3 ZMYM4	2.18e-05	901	74	13	int:H3C1
Interaction	EWSR1 interactions	PRR12 BCL9L SIRT2 SRSF6 MAPT UBAP2L BRD4 NACA BCORL1 LAMP1 LAMP2 UBN2 THRAP3	2.31e-05	906	74	13	int:EWSR1
Interaction	ADAM22 interactions	EPS8 DLGAP1 MAPT PRRT2	2.43e-05	46	74	4	int:ADAM22
Interaction	MYO15A interactions	EPS8 BRD4 MYO15A	2.57e-05	16	74	3	int:MYO15A
Interaction	SPTBN2 interactions	NOLC1 DLGAP1 MAPT LAMP1 LAMP2 AGAP2	4.06e-05	172	74	6	int:SPTBN2
Interaction	CRX interactions	PRR12 BCL9L BCORL1 MECOM UBN2 ZMYM4 ZMYM3	4.08e-05	254	74	7	int:CRX
Interaction	PPP1CA interactions	BCL9L DLGAP1 MAPT BRD4 MYPN NACA PHACTR3 SYNPO2L MECOM MYO16 AGAP2	4.44e-05	696	74	11	int:PPP1CA
Interaction	SHANK2 interactions	DLGAP2 DLGAP1 DLGAP4 AGAP2	4.96e-05	55	74	4	int:SHANK2
Interaction	TRIO interactions	DLGAP1 MAPT NAV2 LAMP1 AGAP2	5.05e-05	109	74	5	int:TRIO
Interaction	SORBS2 interactions	EPS8 DLGAP2 DLGAP1 DLGAP4 AGAP2	5.51e-05	111	74	5	int:SORBS2
Interaction	CDKL5 interactions	DLGAP2 DLGAP1 UBAP2L DLGAP4 LAMP1	6.00e-05	113	74	5	int:CDKL5
Interaction	CAMKV interactions	NOLC1 MAPT BRD4 AFF1 THRAP3	7.38e-05	118	74	5	int:CAMKV
Interaction	SEPTIN5 interactions	DLGAP1 MAPT PRRT2 AGAP2	7.95e-05	62	74	4	int:SEPTIN5
Interaction	AP2A2 interactions	EPS15L1 MAPT LAMP1 PRRT2 EPN1 AGAP2	9.11e-05	199	74	6	int:AP2A2
Interaction	BAIAP2 interactions	EPS8 DLGAP1 MAPT BRD4 LAMP1 C6orf132	9.63e-05	201	74	6	int:BAIAP2
Interaction	CNKSR2 interactions	DLGAP2 DLGAP1 PRKCG AGAP2	1.02e-04	66	74	4	int:CNKSR2
Interaction	FEV interactions	PRR12 SUPT20H MECOM UBN2 ZMYM4 ZMYM3	1.02e-04	203	74	6	int:FEV
Interaction	DCLK1 interactions	MAPT SH3PXD2A LRP2 FAM110B AGAP2	1.04e-04	127	74	5	int:DCLK1
Interaction	MYO5A interactions	DLGAP1 MAPT LAMP1 OS9 LAMP2 AGAP2	1.04e-04	204	74	6	int:MYO5A
Interaction	DLG3 interactions	DLGAP2 DLGAP1 DLGAP4 LRP2 AGAP2	1.21e-04	131	74	5	int:DLG3
Interaction	PIK3R1 interactions	NOLC1 EPS8 MAPT NACA LAMP1 EPN1 MYO16 AGAP2	1.32e-04	412	74	8	int:PIK3R1
Interaction	SYNGAP1 interactions	DLGAP2 DLGAP1 MAPT DLGAP4 KCNQ2 PRKCG AGAP2	1.34e-04	307	74	7	int:SYNGAP1
Interaction	CASK interactions	EPS8 DLGAP2 DLGAP1 MAPT DLGAP4 LAMP1	1.62e-04	221	74	6	int:CASK
Interaction	CYFIP2 interactions	PRR12 DLGAP1 MAPT DLGAP4 LAMP1 MYO16 AGAP2	1.83e-04	323	74	7	int:CYFIP2
Interaction	ARL3 interactions	MAPT SPRR2A BRD4 LAMP2	1.95e-04	78	74	4	int:ARL3
Interaction	DLG4 interactions	EPS8 DLGAP2 DLGAP1 SPRR2A DLGAP4 LRP2 PRKCG AGAP2	2.37e-04	449	74	8	int:DLG4
Interaction	RBBP4 interactions	SRSF6 BRD4 MECOM LAMP2 POLD3 UBN2 CHAMP1 THRAP3 ZMYM3	2.43e-04	573	74	9	int:RBBP4
Interaction	DLG2 interactions	DLGAP2 DLGAP1 LRP2 AGAP2	2.47e-04	83	74	4	int:DLG2
Interaction	DLGAP4 interactions	DLGAP2 DLGAP1 DLGAP4 AGAP2	2.59e-04	84	74	4	int:DLGAP4
Interaction	CSDC2 interactions	MAPT CSDC2	2.76e-04	7	74	2	int:CSDC2
Interaction	KCNA1 interactions	DLGAP1 KCNQ2 PRRT2	2.86e-04	35	74	3	int:KCNA1
Interaction	RASAL2 interactions	DLGAP1 SH3PXD2A LAMP1 FAM110B AGAP2	2.90e-04	158	74	5	int:RASAL2
Interaction	GSC interactions	PRR12 BCL9L BCORL1 MECOM	2.96e-04	87	74	4	int:GSC
Interaction	NBEA interactions	DLGAP1 LAMP1 LAMP2 AGAP2	3.23e-04	89	74	4	int:NBEA
Interaction	HEPACAM interactions	MAPT PRRT2	3.67e-04	8	74	2	int:HEPACAM
Interaction	H3-3A interactions	MAPT BRD4 BCORL1 PHACTR3 UBN2 CHAMP1 THRAP3 CASZ1 ZMYM4 ZMYM3	3.96e-04	749	74	10	int:H3-3A
Interaction	H2AZ1 interactions	MAPT BRD4 EPN1 CHAMP1 THRAP3 ZMYM4 ZMYM3	4.23e-04	371	74	7	int:H2AZ1
Interaction	RIMS1 interactions	MAPT BSN AGAP2	4.26e-04	40	74	3	int:RIMS1
Interaction	CTNND1 interactions	DLGAP1 MAPT BRD4 NACA LAMP1 LAMP2	4.28e-04	265	74	6	int:CTNND1
Interaction	BAG2 interactions	DOCK5 MAPT BRD4 BCORL1 KCNQ2 MECOM PRKCG UBN2 EPN1	4.44e-04	622	74	9	int:BAG2
Interaction	SZT2 interactions	DOCK5 LAMP1 LAMP2	4.58e-04	41	74	3	int:SZT2
Interaction	GRIN2D interactions	DLGAP1 DLGAP4 PRKCG	4.58e-04	41	74	3	int:GRIN2D
Cytoband	Ensembl 112 genes in cytogenetic band chr1p34	MAP7D1 THRAP3 ZMYM4 MMACHC	1.40e-03	294	75	4	chr1p34
GeneFamily	CD molecules\|Mucins	MUC16 MUC2 MUC5AC	2.12e-05	21	47	3	648
GeneFamily	Zinc fingers MYM-type	ZMYM4 ZMYM3	9.86e-05	6	47	2	86
GeneFamily	Armadillo repeat containing\|Protein phosphatase 1 regulatory subunits	MAPT PHACTR3 POLD3 MYO16	1.24e-03	181	47	4	694
GeneFamily	Ankyrin repeat domain containing	CASKIN2 BCORL1 MYO16 AGAP2	3.56e-03	242	47	4	403
ToppCell	3'-Distal_airway-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SLC15A2 SPRR2A MUC16 SCEL MUC5AC C6orf132	5.12e-07	175	75	6	8252ddc2ca95071381f0354aefb70c4714828491
ToppCell	3'-Distal_airway-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SLC15A2 SPRR2A MUC16 SCEL MUC5AC C6orf132	5.12e-07	175	75	6	8ccf60fc469059d7aaf4e6ce54159db2962e0060
ToppCell	PSB-critical-LOC-Epithelial-Squamous\|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	CLCA4 SPRR2A TICAM1 SYNPO2L SCEL C6orf132	6.65e-07	183	75	6	2cf798a2371c61322484ea16fdfae0acfa94f102
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZAN PHACTR3 LRP2 KCNQ2 MYO15A MYO16	6.87e-07	184	75	6	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	NBEAL2 PHACTR3 NAV2 MECOM SCEL MYO16	6.87e-07	184	75	6	29c95b814a0b1ad8734ed68b77df29c08594e5ec
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZAN PHACTR3 LRP2 KCNQ2 MYO15A MYO16	6.87e-07	184	75	6	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZAN PHACTR3 LRP2 KCNQ2 MYO15A MYO16	6.87e-07	184	75	6	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	DOCK5 NBEAL2 NAV2 SCEL MYO16 C6orf132	7.79e-07	188	75	6	43a3a59f92ad93509d4166bd025aed0b1b39a008
ToppCell	facs-Brain_Non-Myeloid-Cortex-24m-Neuronal\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DLGAP2 DLGAP1 KCNQ2 PRKCG PRRT2 BSN	9.08e-07	193	75	6	be28070c049e7cb68bcd54f582226eb2f5e4bc1c
ToppCell	facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-nan\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DLGAP2 DLGAP1 KCNQ2 PRKCG PRRT2 BSN	9.08e-07	193	75	6	0c652ebe22ce5d2927599dd97ef1920547858395
ToppCell	facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-neuron\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DLGAP2 DLGAP1 KCNQ2 PRKCG PRRT2 BSN	9.08e-07	193	75	6	8689a70a33a7c3823dc647d41ac0160e7c3ae396
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway-secretory_cell-Epi-Secretory\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	EPS8 SLC15A2 PHACTR3 MUC16 SCEL C6orf132	1.05e-06	198	75	6	270cecff42b87b7e03f09dd9f99547b287b4598c
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway-secretory_cell\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	EPS8 SLC15A2 PHACTR3 MUC16 SCEL C6orf132	1.05e-06	198	75	6	8b3f4effaaccf8777cde854d5d8a765962f7312b
ToppCell	NS-critical-LOC-Epithelial\|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	EPS8 SPRR2A MUC16 SCEL MUC5AC C6orf132	1.08e-06	199	75	6	d64adb68502be596ce55fb2cb63fe1cfa2c5f8ba
ToppCell	Hippocampus-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2\|Hippocampus / BrainAtlas - Mouse McCarroll V32	NR4A2 PRKCG PRRT2 MYO15A AGAP2	4.99e-06	147	75	5	8f725ff8fb4ced5db2643e80669d3f7945b820ab
ToppCell	facs-Brain_Non-Myeloid-Hippocampus-24m\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KCNQ2 PRKCG BSN EPN1 AGAP2	6.46e-06	155	75	5	72a19a9ecfd13f6769c4b447d3ce01a855ec6ec7
ToppCell	wk_08-11-Mesenchymal-Myofibro_&_SMC-Late_airway_SMC\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	FNDC1 SYNPO2 NR4A2 LMOD1 WDR44	8.25e-06	163	75	5	1e8730d75cccf7292010683ab4e81a69d8e3bfa9
ToppCell	normal_Lung-Fibroblasts-Mesothelial_cells\|Fibroblasts / Location, Cell class and cell subclass	LRP2 MUC16 SCEL PRG4 MUC5AC	9.28e-06	167	75	5	892a2dc83ab5de5a1016402f8e95d2aabf651326
ToppCell	Control\|World / group, cell type (main and fine annotations)	DLGAP1 LRP2 NAV2 MECOM MUC5AC	9.56e-06	168	75	5	a3511faf2cd2c2b9c8363c8b99da3f3609c43ed6
ToppCell	cellseq2-Epithelial-Epithelial_Glandular-Goblet-Goblet\|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	SLC15A2 SPRR2A PHACTR3 MUC16 MUC5AC	1.04e-05	171	75	5	25c1979e972c959e1ce4c57804f976f53a247ad7
ToppCell	cellseq2-Epithelial-Epithelial_Glandular-Goblet\|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	SLC15A2 SPRR2A PHACTR3 MUC16 MUC5AC	1.04e-05	171	75	5	fe27bf581c75ef33c2848878e51ed16b275a4c8e
ToppCell	Control-Epithelial_alveolar-AT_1-Differentiating_AT1\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DLGAP1 SLC15A2 NBEAL2 NAV2 SCEL	1.23e-05	177	75	5	9af14a056eb6d88c6f11b09f6d4c0d3448d647d5
ToppCell	3'-GW_trimst-2-SmallIntestine-Mesenchymal-mesothelial_cell\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	LRP2 MUC16 SCEL PRG4 CSDC2	1.30e-05	179	75	5	056df2aaff750e0e283e7da78fcc3c90c366aac0
ToppCell	3'-GW_trimst-2-SmallIntestine-Mesenchymal-mesothelial_cell-Mesothelium\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	LRP2 MUC16 SCEL PRG4 CSDC2	1.30e-05	179	75	5	f5f3945ef3b9efc5921a71fd51deeb2c80f0ce11
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c01-FCGR3A\|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k)	DOCK5 PHACTR3 AFF1 LAMP2 C6orf132	1.33e-05	180	75	5	12f3c4c4aa7fe03c0ef847bd4d4942c808015f5f
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_ILC-NK_cell\|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k)	DOCK5 PHACTR3 AFF1 LAMP2 C6orf132	1.33e-05	180	75	5	1bc01bb76d0d3f8db74f9244436d3e6d6015ed5d
ToppCell	Control-Epithelial_cells-AT2\|Control / group, cell type (main and fine annotations)	EPS8 DLGAP1 LRP2 ETV5 MECOM	1.33e-05	180	75	5	198b19e7910b4a8cc7e820c525ab357c7f99f578
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_ILC\|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k)	DOCK5 PHACTR3 AFF1 LAMP2 C6orf132	1.33e-05	180	75	5	2a28fbfe10a340c8662c2c8be33792f41fc09088
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PPP2R3A MECOM AFF1 CASZ1 FAM110B	1.37e-05	181	75	5	aa233b652921848af2257cc3687a7a09c3acfb67
ToppCell	COVID-19-Heart-EC_+_Pericyte\|COVID-19 / Disease (COVID-19 only), tissue and cell type	EPS8 SYNPO2 MECOM LMOD1 AGAP2	1.41e-05	182	75	5	e67f3234165199085c793915ebb1f9bbd845e933
ToppCell	5'-GW_trimst-2-LargeIntestine-Mesenchymal-mesothelial_cell-Mesothelium\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	LRP2 MUC16 PRG4 MUC5AC CSDC2	1.44e-05	183	75	5	9d5a363fbe6f0a1668c9d584df65ee1c283349c7
ToppCell	5'-GW_trimst-2-LargeIntestine-Mesenchymal-mesothelial_cell\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	LRP2 MUC16 PRG4 MUC5AC CSDC2	1.44e-05	183	75	5	c5caac6ed6c8d67f5c336281d9fd903976509445
ToppCell	wk_20-22-Mesenchymal-Chondrocyte-intermediate_chondrocyte\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	DLGAP1 PPP2R3A MECOM MMACHC FAM110B	1.44e-05	183	75	5	1464b5c4425e8776c4aeb4d2b560481d4bf13931
ToppCell	343B-Epithelial_cells-Epithelial-I_(AT1)-\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	FNDC1 MAP7D1 NBEAL2 PHACTR3 SCEL	1.48e-05	184	75	5	c7073d1b2c4fdb154d87678b92a0629c02116972
ToppCell	343B-Epithelial_cells-Epithelial-I_(AT1)\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	FNDC1 MAP7D1 NBEAL2 PHACTR3 SCEL	1.48e-05	184	75	5	1ed558a88215b248431c524ea16f13d9022ae98c
ToppCell	facs-Trachea-3m-Epithelial-airway_epithelial\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CLCA4 SLC15A2 SCEL CASZ1 C6orf132	1.56e-05	186	75	5	37b93ebd64ebbd08193a746e5bc9b350c2570733
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	EPS8 DLGAP1 NAV2 ETV5 MECOM	1.56e-05	186	75	5	acfa68a2afb7d2b51c9b469a1965fe5cc5d5e64e
ToppCell	COVID-19-kidney-tDL\|kidney / Disease (COVID-19 only), tissue and cell type	EPS8 DLGAP1 PPP2R3A MAPT LRP2	1.60e-05	187	75	5	d35d27ca3c0e65f92f4508e1cb98a743f44fdcdf
ToppCell	facs-Trachea-nan-3m-Epithelial-basal_epithelial_cell_of_tracheobronchial_tree\|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CLCA4 SLC15A2 SCEL CASZ1 C6orf132	1.60e-05	187	75	5	fe9fc21192ede2eea61f419d20ccda254569d0a6
ToppCell	facs-Brain_Non-Myeloid-Hippocampus-24m-Neuronal-neuron\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KCNQ2 PRKCG BSN EPN1 AGAP2	1.60e-05	187	75	5	e04a84989d624378141042768383b9c846901f2d
ToppCell	facs-Brain_Non-Myeloid-Hippocampus-24m-Neuronal-nan\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KCNQ2 PRKCG BSN EPN1 AGAP2	1.60e-05	187	75	5	24cc03c748e15f7ef0e6509ca5a6ca583fb9c573
ToppCell	facs-Brain_Non-Myeloid-Hippocampus-24m-Neuronal\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KCNQ2 PRKCG BSN EPN1 AGAP2	1.60e-05	187	75	5	2f153b203fe79f206319603cf94d3a03ab49a05d
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	DOCK5 NBEAL2 NAV2 SCEL MYO16	1.64e-05	188	75	5	eea652bab161f19148a883e7e3fe2523b36b3cea
ToppCell	facs-Trachea-3m-Epithelial-airway_epithelial-respiratory_basal_cell\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CLCA4 SLC15A2 SCEL CASZ1 C6orf132	1.64e-05	188	75	5	8ffb5394f7b00ea483a5fe4df894d22fda935e5c
ToppCell	PCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_ASM_(13)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	DLGAP2 FNDC1 SYNPO2 LMOD1 CASZ1	1.64e-05	188	75	5	74f7d216209cabdc96b2d46685b0ae017fdcc8fc
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_mesothelial_(19)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	DLGAP2 FNDC1 LRP2 SCEL PRG4	1.64e-05	188	75	5	9655a4c47b644a870017d349b99063e17dbae572
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_myocytic-mes_ASM_(13)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	DLGAP1 FNDC1 SYNPO2 NAV2 LMOD1	1.64e-05	188	75	5	f54b063025d80de631382bf5326bc40aab7f7d00
ToppCell	facs-Trachea-3m-Epithelial-airway_epithelial-respiratory_basal_cell-basal_epithelial_cell_of_trachea\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CLCA4 SLC15A2 SCEL CASZ1 C6orf132	1.64e-05	188	75	5	137ed9958044fab7a13648affb469585d1c48cf6
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_2-D231\|Adult / Lineage, Cell type, age group and donor	EPS8 DLGAP1 LRP2 ETV5 MECOM	1.69e-05	189	75	5	dab54a52358f66a8a9460cd6089a06c5fa7e7a5d
ToppCell	tumor_Lung-Fibroblasts-Mesothelial_cells\|Fibroblasts / Location, Cell class and cell subclass	SPRR2A LRP2 MUC16 SCEL PRG4	1.73e-05	190	75	5	d82ab67735c1f365d4b0e02b5fa91c64cdc234da
ToppCell	10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Pericyte-A\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	EPS8 SYNPO2 SH3PXD2A LMOD1 CSDC2	1.82e-05	192	75	5	fee99ca7e658963acf968aa724ef8c96cfc00a5d
ToppCell	LA\|World / Chamber and Cluster_Paper	EPS8 LRP2 NAV2 LMOD1 PRG4	1.87e-05	193	75	5	d4bf89437216baf489ea0239136dcedf3b6714af
ToppCell	NS-critical-d_07-13-Epithelial-Squamous\|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	CLCA4 SPRR2A TICAM1 SCEL C6orf132	1.91e-05	194	75	5	53a34843d529ef395deb27086f71f7049a087bab
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Epithelial-Epithelial,_Airway-squamous_epithelial_cell-Epi-Squamous\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	CLCA4 SPRR2A MUC16 SCEL C6orf132	1.96e-05	195	75	5	dd8117dbd22892288f74a7314ab0b5080106936c
ToppCell	facs-Mammary_Gland\|facs / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NOLC1 MAP7D1 NAV2 LMOD1 CSDC2	1.96e-05	195	75	5	21cfcb751e548591fc8724a8329c294da6012e0f
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Epithelial-Epithelial,_Airway-squamous_epithelial_cell\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	CLCA4 SPRR2A MUC16 SCEL C6orf132	1.96e-05	195	75	5	82d87fdb39ec15be9057e2d2ba5c1afb5f97aafe
ToppCell	Goblet_1\|World / shred by cell class for nasal brushing	SPRR2A MUC16 SCEL MUC5AC C6orf132	1.96e-05	195	75	5	d9e4889a2e7b7c97c07c15b043b77837739462e4
ToppCell	10x3'2.3-week_17-19-Mesenchymal_myocytic-stroma-muscle\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	SYNPO2 SIRT2 MYPN PHACTR3 MYO16	1.96e-05	195	75	5	80b973d2a23ef9b101c90e1635e68c9a3f78f65d
ToppCell	COVID-19-Epithelial-Club,_Basal_cells\|COVID-19 / Condition, Lineage and Cell class	CLCA4 SLC15A2 MUC16 MECOM MUC5AC	2.01e-05	196	75	5	dd32046067d93b9484cfbf1d7826a436a3d9f0e9
ToppCell	critical-Epithelial-Squamous\|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	CLCA4 SPRR2A TICAM1 SCEL C6orf132	2.06e-05	197	75	5	cfbdaada7169afb68455724ae87032ff311b2d89
ToppCell	critical-Epithelial-Squamous\|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	CLCA4 SPRR2A TICAM1 SCEL C6orf132	2.06e-05	197	75	5	eccc80d6ab79c46b10108de1cff3abeacfc105cd
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Epithelial-Epithelial,_Airway\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	CLCA4 SPRR2A MUC16 SCEL MUC5AC	2.06e-05	197	75	5	ac9c0c25cfeaabd53d332982c73fc6c47b0c6478
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Epithelial\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	CLCA4 SPRR2A MUC16 SCEL MUC5AC	2.06e-05	197	75	5	b57d2e3413ef6dd1da56c45087926f2f3eab876c
ToppCell	LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT1\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	SLC15A2 NBEAL2 NAV2 SCEL FCAMR	2.16e-05	199	75	5	d43c605a4ff221cf78d91678c15d2ad20f831c7f
ToppCell	NS-moderate-d_07-13-Epithelial\|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	SPRR2A MUC16 SCEL MUC5AC C6orf132	2.21e-05	200	75	5	85940b4bf7971b872469dea8b8d7a45bdeb2a909
ToppCell	5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CLCA4 SLC15A2 MUC16 MUC5AC C6orf132	2.21e-05	200	75	5	b68d212159b9d04866ba02ff55c35be247805eec
ToppCell	3'-GW_trimst-1-SmallIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_2_(ZEB2+)\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	EPS8 FNDC1 SYNPO2 MYO16 FAM110B	2.21e-05	200	75	5	ac8a5d71acd4d401995babd233f0d3738e8ad2a5
ToppCell	droplet-Lung-30m-Hematologic-myeloid-interstitial_macrophage-interstitial_macrophage_l14\|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	MAPT POLD3 UBN2 PRG4	3.11e-05	106	75	4	ede8407ad253080d1fa2a6e2aacf549ce220309a
ToppCell	Control-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DLGAP1 PHACTR3 KCNQ2 MYO16	5.92e-05	125	75	4	b162a5bfbb8ac5e65e13578fef9de442a9e4fd8b
ToppCell	TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligoastrocytoma-2\|TCGA-Brain / Sample_Type by Project: Shred V9	SPRR2A SCEL MUC2 MYO16	8.94e-05	139	75	4	6f6c64eaa1ce84e0aa9a0caa9c4d9bf7afe626df
ToppCell	E16.5-samps-Mesenchymal-Myofibroblast-Smooth_Muscle-like_MyoFibroblast\|E16.5-samps / Age Group, Lineage, Cell class and subclass	DOCK5 SYNPO2 RTL9 LMOD1	9.20e-05	140	75	4	5623a0a68403fc00166b7d13d13e184a718d9bdd
ToppCell	3'-GW_trimst-1-SmallIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	SYNPO2 LMOD1 PRG4 MMACHC	9.98e-05	143	75	4	39060dc1d87505a16e2df95140087c731f099570
ToppCell	TCGA-Endometrium-Primary_Tumor-Endometrial_Adenocarcinoma-Endometrioid-7\|TCGA-Endometrium / Sample_Type by Project: Shred V9	SYNPO2 SYNPO2L LMOD1 CSDC2	1.05e-04	145	75	4	ffbdadea0185e5d3b85f2868d5ec82b50cf2e2a1
ToppCell	343B-Epithelial_cells-Epithelial-E_(AT2)-\|343B / Donor, Lineage, Cell class and subclass (all cells)	EPS8 PHACTR3 SCEL MMACHC	1.05e-04	145	75	4	80684ec249fa445c1b35f94608a4a6824d53f2d9
ToppCell	343B-Epithelial_cells-Epithelial-E_(AT2)\|343B / Donor, Lineage, Cell class and subclass (all cells)	EPS8 PHACTR3 SCEL MMACHC	1.05e-04	145	75	4	cb534333fba44b241b14fb0d7b74e843f4e7f9f8
ToppCell	Adult-Mesenchymal-chondrocyte-D122\|Adult / Lineage, Cell type, age group and donor	SYNPO2L NAV2 LMOD1 PRG4	1.14e-04	148	75	4	81a1e6fdd942a612bf523c59b8b4974f6ca1fdce
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	EPS8 NAV2 MECOM SCEL	1.14e-04	148	75	4	9fe3c0a5904b8e9a0f28130f8d84d4f2a819b06c
ToppCell	PBMC-Control-cDC_2\|Control / Compartment, Disease Groups and Clusters	MUC16 PRRT2 PRG4 MYO16	1.30e-04	153	75	4	4ee37266b0054f276c7a73ab9220f681b9d74c71
ToppCell	3'-Distal_airway-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SLC15A2 MUC16 MUC5AC FCAMR	1.36e-04	155	75	4	62b59cb32b12bd55b19e98786a866d788fc9e4bf
ToppCell	PND07-Immune-Immune_Myeloid-DC-cDC2-cDC2_prolif\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	NBEAL2 KCNQ2 MCRS1 MMACHC	1.36e-04	155	75	4	b5d5c38b269e9318970fcce564df1c8ed7a7ccc6
ToppCell	TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligoastrocytoma\|TCGA-Brain / Sample_Type by Project: Shred V9	DLGAP1 SYNPO2 MAPT CSDC2	1.58e-04	161	75	4	347edb0de10850b7d16c40945751033289289c9b
ToppCell	AT1_cells-IPF_01\|World / lung cells shred on cell class, cell subclass, sample id	FNDC1 PHACTR3 SCEL MYO16	1.61e-04	162	75	4	ae2ba4f21f6f6c512006fa531d670b88be7c04c9
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Principal_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CLCA4 MECOM CASZ1 MYO16	1.61e-04	162	75	4	285e6d553f485fd9f1075c4e1b940da251b5ea35
ToppCell	AT1-AT2_cells-IPF_01\|World / lung cells shred on cell class, cell subclass, sample id	PHACTR3 KCNQ2 SCEL C6orf132	1.61e-04	162	75	4	57d627259d27f39885bf416d74bcb6656db6e27b
ToppCell	normal_Lung-Fibroblasts-Myofibroblasts\|Fibroblasts / Location, Cell class and cell subclass	FNDC1 SH3PXD2A RTL9 BSN	1.69e-04	164	75	4	9b4a6007abae992db871d9f6f731d5af724de30d
ToppCell	P07-Epithelial-alveolar_epithelial_cell-type_II_pneumocyte\|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	EPS8 SLC15A2 LRP2 ETV5	1.77e-04	166	75	4	021b9344de7957762f81b09a647504b8c8289cf1
ToppCell	PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_prolif\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SYNPO2 MYPN SYNPO2L LMOD1	1.81e-04	167	75	4	91b14df450bfb6a2b406c88f8c75cd51eeb9e82b
ToppCell	368C-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-2\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	CASKIN2 BCORL1 ETV5 C6orf132	1.85e-04	168	75	4	3fb79aaa858057c82645a90bd139fc4f096323c7
ToppCell	368C-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-2\|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells)	CASKIN2 BCORL1 ETV5 C6orf132	1.90e-04	169	75	4	0589f39d8e9468e42d25d30ff70bb7cb8b921628
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-proliferative_fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	SYNPO2 PHACTR3 NAV2 LMOD1	1.90e-04	169	75	4	a84490724a206c9bbb145f7ce08613f91d100ac4
ToppCell	Control-Epithelial_cells-ECM-high_epithelial\|Control / group, cell type (main and fine annotations)	NAV2 MECOM SCEL MYO16	1.94e-04	170	75	4	e2023d66e70983c87dacbd6181d3426488d1fc57
ToppCell	Adult-Mesenchymal-airway_smooth_muscle_cell\|Adult / Lineage, Cell type, age group and donor	FNDC1 SYNPO2 LMOD1 CSDC2	2.07e-04	173	75	4	a5331721bd9f9a66530dd4ffe28cb3a5a8cad8fc
ToppCell	wk_20-22-Epithelial-Proximal_epithelial-Squamous\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	CLCA4 SPRR2A SCEL C6orf132	2.12e-04	174	75	4	0a4721248ec89bc98ebe119de6e19fbfca8b5098
ToppCell	Control-Epithelial_cells-AT1\|Control / group, cell type (main and fine annotations)	NAV2 MECOM SCEL MYO16	2.12e-04	174	75	4	548d7f2b958a2bfd2c95eb049ceaab55a559c77d
ToppCell	COVID-matDC-\|COVID / Condition, Cell_class and T cell subcluster	SYNPO2 NAV2 LMOD1 FAM110B	2.17e-04	175	75	4	db5e170411dfa62074c4b8311bb8c589d1c4279b
ToppCell	COVID-matDC\|COVID / Condition, Cell_class and T cell subcluster	SYNPO2 NAV2 LMOD1 FAM110B	2.17e-04	175	75	4	e2b638109c9ffd10430e6e134035622b7605ce23
ToppCell	droplet-Lung-LUNG-30m-Epithelial\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LRP2 ETV5 FCAMR C6orf132	2.21e-04	176	75	4	5201f003192c033655ba47f0faf8c47a96eae03d
ToppCell	Fetal_29-31_weeks-Epithelial-club_cell-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	EPS8 NAV2 MECOM CASZ1	2.21e-04	176	75	4	3bbac5c2397535631fce8fa98f6ddb4fe0260351
ToppCell	PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SYNPO2 MYPN SYNPO2L LMOD1	2.26e-04	177	75	4	c9b02a2e1ff2aa18c37e88a53b06a5b696a442ae
ToppCell	P28-Mesenchymal-mesenchymal_fibroblast-mesothelial_cell_of_visceral_pleura\|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	LRP2 MUC16 PRG4 C6orf132	2.31e-04	178	75	4	1e05bc26591fea16e29bcfc5f538dda1dc427f05
Drug	Triamcinolone [124-94-7]; Up 200; 10.2uM; PC3; HT_HG-U133A	DOCK5 CASKIN2 TICAM1 BCORL1 NAV2 ETV5 CASZ1	3.44e-06	193	75	7	2078_UP
Disease	Paroxysmal atrial fibrillation	PPP2R3A MAPT SH3PXD2A MYPN NACA SYNPO2L NAV2 CASZ1	5.12e-09	156	73	8	C0235480
Disease	familial atrial fibrillation	PPP2R3A MAPT SH3PXD2A MYPN NACA SYNPO2L NAV2 CASZ1	5.12e-09	156	73	8	C3468561
Disease	Persistent atrial fibrillation	PPP2R3A MAPT SH3PXD2A MYPN NACA SYNPO2L NAV2 CASZ1	5.12e-09	156	73	8	C2585653
Disease	Atrial Fibrillation	PPP2R3A MAPT SH3PXD2A MYPN NACA SYNPO2L NAV2 CASZ1	6.25e-09	160	73	8	C0004238
Disease	testosterone measurement	DOCK5 DLGAP1 ZAN MAPT SH3PXD2A DLGAP4 MYPN RTL9 BCORL1 MECOM AFF1 MYO15A CHAMP1 MYO16 FAM110B	4.33e-07	1275	73	15	EFO_0004908
Disease	cystitis (is_marker_for)	MUC2 MUC5AC	6.04e-06	2	73	2	DOID:1679 (is_marker_for)
Disease	Abnormal behavior	PRR12 BCORL1 NR4A2	7.95e-06	16	73	3	C0233514
Disease	keratoconjunctivitis (is_marker_for)	MUC16 MUC5AC	1.81e-05	3	73	2	DOID:9368 (is_marker_for)
Disease	sputum mucin-5B amount	MUC2 MUC5AC	1.81e-05	3	73	2	OBA_2050332
Disease	atrial fibrillation	PPP2R3A MAPT SH3PXD2A NACA SYNPO2L NAV2 CASZ1	3.75e-05	371	73	7	EFO_0000275
Disease	mucinous adenocarcinoma (is_marker_for)	MUC2 MUC5AC	6.01e-05	5	73	2	DOID:3030 (is_marker_for)
Disease	cognitive disorder (implicated_via_orthology)	MAPT LAMP2	9.00e-05	6	73	2	DOID:1561 (implicated_via_orthology)
Disease	Familial benign neonatal epilepsy	KCNQ2 PRRT2	9.00e-05	6	73	2	C0220669
Disease	Intellectual Disability	PRR12 BRD4 NR4A2 LRP2 PRKCG PRRT2 CHAMP1	1.20e-04	447	73	7	C3714756
Disease	blood urea nitrogen measurement	DLGAP1 SYNPO2 PPP2R3A SLC15A2 LRP2 MECOM CASZ1	1.29e-04	452	73	7	EFO_0004741
Disease	hematocrit	PRR12 ZAN SLC15A2 MAPT BCORL1 LRP2 MECOM AFF1 POLD3 BSN	1.87e-04	1011	73	10	EFO_0004348
Disease	cardiac troponin T measurement	DLGAP2 DLGAP1 SYNPO2 MAPT MECOM	2.14e-04	219	73	5	EFO_0005043
Disease	bringing up phlegm, sputum or mucus on most days, self-reported	MUC2 MUC5AC	2.15e-04	9	73	2	EFO_0009824
Disease	pneumonia	BCL9L MUC2 MUC5AC	2.18e-04	47	73	3	EFO_0003106
Disease	dry eye syndrome (is_marker_for)	MUC16 MUC5AC	2.68e-04	10	73	2	DOID:10140 (is_marker_for)
Disease	Parkinson disease, late-onset	MAPT NR4A2	2.68e-04	10	73	2	cv:C3160718
Disease	PARKINSON DISEASE, LATE-ONSET	MAPT NR4A2	2.68e-04	10	73	2	168600
Disease	PARKINSON DISEASE, LATE-ONSET	MAPT NR4A2	3.92e-04	12	73	2	C3160718
Disease	white matter microstructure measurement	DOCK5 MAPT SH3PXD2A LRP2 NAV2 MECOM	4.14e-04	390	73	6	EFO_0005674
Disease	cholangiocarcinoma (is_marker_for)	MUC16 MUC2 MUC5AC	5.43e-04	64	73	3	DOID:4947 (is_marker_for)
Disease	pentachlorophenol measurement	DLGAP2 PHACTR3 MUC16	7.98e-04	73	73	3	EFO_0022071
Disease	parathion measurement	DLGAP2 PHACTR3 MUC16	7.98e-04	73	73	3	EFO_0022070
Disease	potassium chromate measurement	DLGAP2 PHACTR3 MUC16	7.98e-04	73	73	3	EFO_0022072
Disease	mercuric chloride measurement	DLGAP2 PHACTR3 MUC16	7.98e-04	73	73	3	EFO_0022068
Disease	heptachlor epoxide measurement	DLGAP2 PHACTR3 MUC16	7.98e-04	73	73	3	EFO_0022067
Disease	methoxychlor measurement	DLGAP2 PHACTR3 MUC16	7.98e-04	73	73	3	EFO_0022069
Disease	4,6-dinitro-o-cresol measurement	DLGAP2 PHACTR3 MUC16	7.98e-04	73	73	3	EFO_0022053
Disease	2,4,5-trichlorophenol measurement	DLGAP2 PHACTR3 MUC16	7.98e-04	73	73	3	EFO_0022052
Disease	azinphos methyl measurement	DLGAP2 PHACTR3 MUC16	7.98e-04	73	73	3	EFO_0022055
Disease	aldrin measurement	DLGAP2 PHACTR3 MUC16	7.98e-04	73	73	3	EFO_0022054
Disease	dicofol measurement	DLGAP2 PHACTR3 MUC16	7.98e-04	73	73	3	EFO_0022060
Disease	disulfoton measurement	DLGAP2 PHACTR3 MUC16	7.98e-04	73	73	3	EFO_0022062
Disease	dieldrin measurement	DLGAP2 PHACTR3 MUC16	7.98e-04	73	73	3	EFO_0022061
Disease	endrin measurement	DLGAP2 PHACTR3 MUC16	7.98e-04	73	73	3	EFO_0022064
Disease	endosulfan measurement	DLGAP2 PHACTR3 MUC16	7.98e-04	73	73	3	EFO_0022063
Disease	heptachlor measurement	DLGAP2 PHACTR3 MUC16	7.98e-04	73	73	3	EFO_0022066
Disease	ethion measurement	DLGAP2 PHACTR3 MUC16	7.98e-04	73	73	3	EFO_0022065
Disease	chlorpyrifos measurement	DLGAP2 PHACTR3 MUC16	7.98e-04	73	73	3	EFO_0022057
Disease	cadmium chloride measurement	DLGAP2 PHACTR3 MUC16	7.98e-04	73	73	3	EFO_0022056
Disease	diazinon measurement	DLGAP2 PHACTR3 MUC16	7.98e-04	73	73	3	EFO_0022059
Disease	dibutyl phthalate measurement	DLGAP2 PHACTR3 MUC16	7.98e-04	73	73	3	EFO_0022058
Disease	environmental exposure measurement	DLGAP2 PHACTR3 MUC16	7.98e-04	73	73	3	EFO_0008360
Disease	DDT metabolite measurement	DLGAP2 PHACTR3 MUC16	8.30e-04	74	73	3	EFO_0007886
Disease	vital capacity	MAPT BRD4 MYPN RTL9 LRP2 MECOM AFF1 CHAMP1 CASZ1 MYO16	9.05e-04	1236	73	10	EFO_0004312
Disease	Splenomegaly	MAPT MECOM	1.35e-03	22	73	2	C0038002
Disease	Parkinson disease	MAPT NR4A2	1.35e-03	22	73	2	cv:C0030567
Disease	PR interval	CASKIN2 SH3PXD2A SYNPO2L NAV2 AFF1 THRAP3	1.42e-03	495	73	6	EFO_0004462
Disease	Sjogren's syndrome (is_marker_for)	MUC16 MUC5AC	1.61e-03	24	73	2	DOID:12894 (is_marker_for)
Disease	traumatic brain injury (biomarker_via_orthology)	MAPT LAMP2	1.61e-03	24	73	2	DOID:0081292 (biomarker_via_orthology)
Disease	Colorectal Carcinoma	SRSF6 NR4A2 LRP2 MCRS1 POLD3 ZMYM4 FAM110B	1.75e-03	702	73	7	C0009402
Disease	Inhalant adrenergic use measurement	MUC16 MUC2 MUC5AC	1.76e-03	96	73	3	EFO_0009941
Disease	blood cobalt measurement	DLGAP2 PHACTR3 MUC16	2.03e-03	101	73	3	EFO_0007577
Disease	sleep duration	PRR12 PPP2R3A MAPT LMOD1 ZMYM4	2.05e-03	362	73	5	EFO_0005271
Disease	Hyperplasia	BRD4 PRG4	2.19e-03	28	73	2	C0020507
Disease	cytotoxicity measurement, response to clozapine	DLGAP2 PRG4	2.35e-03	29	73	2	EFO_0006952, GO_0097338
Disease	Child Development Disorders, Specific	LRP2 KCNQ2	2.35e-03	29	73	2	C0085997
Disease	Child Development Deviations	LRP2 KCNQ2	2.35e-03	29	73	2	C0085996

Protein segments in the cluster

Peptide	Gene	Start	Entry
PLSPPPAPKSAPSKV	ATP6V1FNB	61	A0A1B0GUX0
PAPKSAPSKVPSPVP	ATP6V1FNB	66	A0A1B0GUX0
PIPPKKPGLTPSPSA	CTTNBP2NL	581	Q9P2B4
PPRPKPPSGKSTPVS	EPS15L1	786	Q9UBC2
PAVPPPTKVVAPPSS	BRD4	471	O60885
AETKPPMAPSSPPVP	CASZ1	1076	Q86V15
PTPVKPTEPCTPSKS	BCORL1	1451	Q5H9F3
APPPPAPKPCKTVTT	AGAP2	181	Q99490
TPPPVPPRTTTKPFI	DLGAP1	541	O14490
KTPPPVPPRTTSKPL	DLGAP2	611	Q9P1A6
PPPVPPRTTSKPFIS	DLGAP4	561	Q9Y2H0
SVPPPSAPPPKKSLG	NOLC1	291	Q14978
EKPLTPVPSKPPVTP	MECOM	751	Q03112
PSPPFVKETSPPSSP	MUC16	7676	Q8WXI7
ETKPPTPAPPKDVTP	MYO15A	1026	Q9UKN7
SSSLPSPRKQPPPKP	MYO16	1286	Q9Y6X6
KPPPETTPTPATPKV	BSN	621	Q9UPA5
RKDPPPEPSPSKGSP	KCNQ2	406	O43526
PSPQPSPKPSPKNSP	LMOD1	511	P29536
PTPSKPSSTPSKPTP	MUC2	4391	Q02817
PSSTPSKPTPGTKPP	MUC2	4396	Q02817
PSPTTTPTPKEKPEA	LAMP2	206	P13473
KPPSGFKPLTPPTTP	ETV5	126	P41161
SSPIPSPSPSPTDPK	PRKCG	321	P05129
ATPPPSPSLPAKPKP	LRP2	4611	P98164
VKKTFSTPSPPPVPA	MUC5AC	1906	P98088
PSPDLPFTTPAPKKP	MMACHC	246	Q9Y4U1
EKKPGTPLPPPATSP	PPP2R3A	671	Q06190
KGPPPPPPKRLSSVS	CASKIN2	866	Q8WXE0
PAPEPHSPPSKKSPP	PRRT2	196	Q7Z6L0
SSSPALKPKPNPPSP	C6orf132	436	Q5T0Z8
SVKAPAPIPESPPSK	FCAMR	256	Q8WWV6
PPPPPKARKSGIPTS	DOCK5	1851	Q9H7D0
PSKPASVSSPEPPKS	CHAMP1	176	Q96JM3
KPEKPEPSSPSPRAP	FNDC1	471	Q4ZHG4
KVPPTPEPLPLSTPS	BCL9L	281	Q86UU0
KVSKAPSTPVPPSPA	MCRS1	96	Q96EZ8
PPKPPSPRGTTASPK	MAP7D1	491	Q3KQU3
PCSSSAPPLPPKPKI	FAM110B	216	Q8TC76
PPAATPTPTPPTRKT	EPN1	456	Q9Y6I3
PSPSPSPVPKSPSVD	LAMP1	206	P11279
MTSPCSPPLKPPISP	C19orf54	1	Q5BKX5
PLPPSTPAPVPVSKV	EPS8	636	Q12929
TSPPVVPPLHSPKSP	CSDC2	6	Q9Y534
PPSPPKKPSPTICGS	SLC15A2	26	Q16348
PSKPKSPQEPSPPSP	NR4A2	346	P43354
PPLLPTPPPKASSKT	PHACTR3	231	Q96KR7
TTPETAKPPPKEVPS	RTL9	1126	Q8NET4
VTPKTPPPMAPKTPP	SYNPO2L	701	Q9H987
LKPPSPPKSPTRDTP	NKPD1	541	Q17RQ9
SPESPTSPKPAPPKP	NBEAL2	1306	Q6ZNJ1
TSPKPAPPKPPTESP	NBEAL2	1311	Q6ZNJ1
DKSKPVTSPPPPPSS	NAV2	316	Q8IVL1
PNPSTSASPKKSPPP	SIRT2	361	Q8IXJ6
PVPPSKARSVSPPPK	SRSF6	306	Q13247
PVPKTEPEPPSVKSS	POLD3	361	Q15054
APAPPPKPETPEKTT	PRR12	1696	Q9ULL5
SPGIAPKPKTPPTAP	PROB1	811	E7EW31
TPKEPTPTTPKEPAS	PRG4	346	Q92954
PAPTTTKEPAPTTPK	PRG4	396	Q92954
TKEPAPTTPKEPAPT	PRG4	401	Q92954
PTTPKEPAPTTTKEP	PRG4	406	Q92954
KSAPTTPKEPAPTTP	PRG4	426	Q92954
TTPKEPAPTTPKEPT	PRG4	446	Q92954
PAPTTPKEPTPTTPK	PRG4	451	Q92954
PKEPTPTTPKEPAPT	PRG4	456	Q92954
PTTPKEPAPTTKEPA	PRG4	461	Q92954
EPAPTTKEPAPTTPK	PRG4	466	Q92954
TKEPAPTTPKEPAPT	PRG4	471	Q92954
EPAPTAPKKPAPTTP	PRG4	481	Q92954
APTTPKEPAPTTPKE	PRG4	491	Q92954
KEPAPTTPKEPAPTT	PRG4	496	Q92954
PAPTTTKEPSPTTPK	PRG4	506	Q92954
TKEPSPTTPKEPAPT	PRG4	511	Q92954
PTTPKEPSPTTTKEP	PRG4	546	Q92954
TTKEPAPTTPKEPAP	PRG4	556	Q92954
PAPTTPKEPAPTTPK	PRG4	576	Q92954
PKEPAPTTPKEPAPT	PRG4	581	Q92954
EPAPTTTKKPAPTTP	PRG4	591	Q92954
APTTPKEPAPTTPKE	PRG4	601	Q92954
PTPTTPEEPAPTTPK	PRG4	656	Q92954
TPKEPAPTTPKEPAP	PRG4	676	Q92954
APTTPKEPAPTTPKE	PRG4	681	Q92954
KEPAPTTPKEPAPTT	PRG4	686	Q92954
PAPTTPKETAPTTPK	PRG4	696	Q92954
TPKEPAPTTPKEPAP	PRG4	761	Q92954
TAPTTPKEPAPTTPK	PRG4	826	Q92954
PTTPKKPAPTTPETP	PRG4	836	Q92954
KPAPTTPETPPPTTS	PRG4	841	Q92954
VVPKKPPPSPQPTEE	OS9	521	Q13438
DPPPKSSSKAPRAPP	AFF1	561	P51825
PPPPVSSSSQKPAKP	AFF1	866	P51825
DPTPTPTPTPTPDKS	CLCA4	876	Q14CN2
RPSPVPKPSPPLSST	THRAP3	266	Q9Y2W1
ASPKPATSPKPLPSP	UBN2	1041	Q6ZU65
PLPSPKPSASPKPSL	UBN2	1051	Q6ZU65
TAAPPPPSSPLPSKS	UBAP2L	446	Q14157
PPPVAPKPAVKSSSS	SYNPO2	756	Q9UMS6
EPSTAPPKPKPPPLT	TMIE	31	Q8NEW7
TLTRPKVPPPAPPSK	SH3PXD2A	516	Q5TCZ1
PVTPSPPCQSKYPPK	SPRR2A	56	P35326
TKPCPPTPTTPETSP	TICAM1	346	Q8IUC6
VHPPIPPKPSSPVSS	SCEL	186	O95171
KSPTPPPSSKPSSIP	SUPT20H	491	Q8NEM7
ASTKKPVPARPPPPT	WDR44	226	Q5JSH3
TRIPAKTPPAPKTPP	MAPT	486	P10636
KTPPAPKTPPSSGEP	MAPT	491	P10636
DPPKQSPGSTSPKPP	RRP8	166	O43159
PVKTRSAPTAPTPPP	ZMYM3	806	Q14202
PPARPPPPLTKKTCS	ZMYM4	376	Q5VZL5
PEKPTTPTEKPTISP	ZAN	756	Q9Y493
KVPAPFSPPPSKPRS	KIAA1522	606	Q9P206
KGAPTPPAVTPPSPK	NACA	1006	E9PAV3
TPPSPKEPPAPKQVA	NACA	1471	E9PAV3
PAPKGTPTSPPVTPS	NACA	1631	E9PAV3
ATKTPEPSSPVKEPP	MYPN	636	Q86TC9